Lab and biomanufacturing automation
Robots that run laboratory protocols and manufacture cell and gene therapies. 7 companies reviewed across 3 subcategories.
Liquid-handling robots 2
Benchtop and floor-standing robots that pipette and prepare samples.
8.0/10Opentrons review
Open-source benchtop liquid handling robots for life science labs, with list prices published from $15,950, and AI tools for designing protocols.
Strongest: Pricing transparency 9.0
6.6/10SPT Labtech review
Melbourn, England maker of mosquito, dragonfly, and firefly low-volume liquid handlers; UK company turnover GBP 50.5M in 2025; owned by EQT since 2022.
Strongest: Product maturity 9.0
Lab workcells and orchestration 4
Integrated robotic workcells and scheduling software that link lab instruments.
6.5/10Labman review
UK family-run builder of custom laboratory automation systems and benchtop products (MultiDose, MultiVial, TIDAS); North Yorkshire; founded 1979.
Strongest: Product maturity 7.5
6.3/10Hudson Lab Automation review
US lab automation maker combining Hudson Robotics, Art Robbins Instruments, and Tomtec: liquid handlers, microplate handlers, colony pickers, pH meters, protein crystallization tools, software, and integrated work cells; New Providence, New Jersey.
Strongest: Product maturity 8.0
6.1/10HighRes Biosolutions review
Beverly, Massachusetts maker of modular lab automation workcells, the AutoPod mobile robot, and Cellario orchestration software; owned by Axel Johnson since 2015; about $36M revenue (Kona Equity estimate).
Strongest: Product maturity 8.0
5.4/10Automata review
LINQ robotic lab benches and orchestration software that tie existing instruments into automated workcells, with Danaher as a strategic investor.
Strongest: Product maturity 6.5
Cell therapy manufacturing robots 1
Automated systems that manufacture cell and gene therapies.
